Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.

Flemming Bendtsen; N Ebbehøj; J Fallingborg; K Abildgaard; P B Mortensen; Peter Matzen; E Krag; H Kromann-Andersen

Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.

Bidragets oversatte titel: Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.

Flemming Bendtsen, N Ebbehøj, J Fallingborg, K Abildgaard, P B Mortensen, Peter Matzen, E Krag, H Kromann-Andersen

Institut for Klinisk Medicin

Abstract

Seventy-seven patients with endoscopically verified duodenal ulcers were randomized to treatment with either 2 g sucralfate daily at bedtime or 1 g sucralfate q.d.s. in a controlled double-blind comparative study. After a 4-week treatment period, the healing rate was 68% for the former and 69% for the latter treatment.

Bidragets oversatte titel	Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.
Originalsprog	Engelsk
Tidsskrift	Alimentary Pharmacology and Therapeutics
Vol/bind	4
Udgave nummer	1
Sider (fra-til)	97-99
Antal sider	3
ISSN	0269-2813
Status	Udgivet - 1990

Adgang til dokumentet

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2104077&query_hl=102

Citationsformater

Bendtsen, F., Ebbehøj, N., Fallingborg, J., Abildgaard, K., Mortensen, P. B., Matzen, P., Krag, E., & Kromann-Andersen, H. (1990). Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily. Alimentary Pharmacology and Therapeutics, 4(1), 97-99. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2104077&query_hl=102

Bendtsen, F, Ebbehøj, N, Fallingborg, J, Abildgaard, K, Mortensen, PB, Matzen, P, Krag, E & Kromann-Andersen, H 1990, 'Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.', Alimentary Pharmacology and Therapeutics, bind 4, nr. 1, s. 97-99. <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=2104077&query_hl=102>

@article{9acb6d38dccd413d8480f61e2d35e55a,

title = "Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.",

abstract = "Seventy-seven patients with endoscopically verified duodenal ulcers were randomized to treatment with either 2 g sucralfate daily at bedtime or 1 g sucralfate q.d.s. in a controlled double-blind comparative study. After a 4-week treatment period, the healing rate was 68% for the former and 69% for the latter treatment.",

author = "Flemming Bendtsen and N Ebbeh{\o}j and J Fallingborg and K Abildgaard and Mortensen, {P B} and Peter Matzen and E Krag and H Kromann-Andersen",

year = "1990",

language = "English",

volume = "4",

pages = "97--99",

journal = "Alimentary Pharmacology and Therapeutics, Supplement",

issn = "0953-0673",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily.

AU - Bendtsen, Flemming

AU - Ebbehøj, N

AU - Fallingborg, J

AU - Abildgaard, K

AU - Mortensen, P B

AU - Matzen, Peter

AU - Krag, E

AU - Kromann-Andersen, H

PY - 1990

Y1 - 1990

N2 - Seventy-seven patients with endoscopically verified duodenal ulcers were randomized to treatment with either 2 g sucralfate daily at bedtime or 1 g sucralfate q.d.s. in a controlled double-blind comparative study. After a 4-week treatment period, the healing rate was 68% for the former and 69% for the latter treatment.

AB - Seventy-seven patients with endoscopically verified duodenal ulcers were randomized to treatment with either 2 g sucralfate daily at bedtime or 1 g sucralfate q.d.s. in a controlled double-blind comparative study. After a 4-week treatment period, the healing rate was 68% for the former and 69% for the latter treatment.

M3 - Journal article

SN - 0953-0673

VL - 4

SP - 97

EP - 99

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

IS - 1

ER -